Baha® BI300 Implant
The Baha® System's BI300 implant is built on decades of industry leadership, knowledge and experience. Learn more about the implant and Baha System options.
Baha Implant
Decades of bone conduction leadership
A history of innovation
Built on a tiny implant foundation, today's Baha System follows decades of Cochlear's leadership and innovation in the bone conduction hearing space. The traditional bone conduction solution remains a trusted option for those patients who cannot access or are not suitable for the active Osia System.
A stable foundation
The BI300 Implant features a unique TiOblast™ surface coating, designed to aid osseointegration with excellent contact surface area. The BI300 Implant serves as a stable foundation for efficient sound transmission, and its stability and reliability are backed by more than 10 years of cumulative research time in published clinical studies.1-4
System options
Two attachment methods
Baha Connect System
The Baha Connect System is a traditional percutaneous bone conduction implant system. It uses a small abutment to attach the sound processor (with transducer) directly to the BI300 Implant. It's designed to maximise sound transmision and avoid skin attenuation.
Our unique DermaLock™ Abutment is clinically shown to integrate with soft tissue5, and it is available in a range of lengths to suit the patient's individual needs.
Learn more about Cochlear bone conduction solutions
Learn more about our most advanced bone conduction system, the active Osia System with unique Piezo Power™ technology.
Learn more about the Baha System, our traditional bone conduction system that has driven decades of industry leadership.
Learn more about the latest Baha System sound processor, the powerfully small, better connected Baha 7 Sound Processor.
Learn more about how Baha Start connects patients with sound before they're ready for surgery.
Disclaimer
This material is intended for health professionals. If you are a consumer, please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
For a full list of Cochlear’s trademarks, please visit our Terms of Use page.
The TiOblast surface technology is licensed from DENTSPLY and TiOblast is a trademark of DENTSPLY.
References
- Östblom A. Clinical Investigation Report 6-month final analysis. Cochlear Limited, Australia. 2020; CBAS5751 / D1703580.
- Design Verification Report Osia System R5. Cochlear Limited, Australia. 2023; D2043008.
- Design Validation Report Osia System. Cochlear Limited, Australia. 2023; D1575872.
- Andersson V. Literature search and evaluation: BI300 implant years and survival rate. Cochlear Bone Anchored Solutions AB, Sweden. 2019; D1322539.
- van Hoof M, Wigren S, Duimel H, Savelkoul PH, Flynn M, Stokroos RJ. Can the hydroxyapatite-coated skin-penetrating abutment for bone conduction hearing implants integrate with the surrounding skin: Front Surg. 2015 Sep 14;2:45.